| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.777 | 0.004 | 0.777 | MAP kinase 1 inhibitor | 0.735 0.004 DBMET03736 0.759 0.004 DBMET03737 | ||
| 0.747 | 0.004 | 0.747 | Src kinase inhibitor | 0.736 0.004 DBMET03736 0.641 0.005 DBMET03737 | ||
| 0.74 | 0.004 | 0.74 | c-Src kinase inhibitor | 0.723 0.004 DBMET03736 0.629 0.004 DBMET03737 | ||
| 0.542 | 0.014 | 0.542 | Tyrosine kinase inhibitor | 0.513 0.017 DBMET03736 0.419 0.026 DBMET03737 | ||
| 0.531 | 0.007 | 0.531 | ErbB-1 antagonist | 0.503 0.008 DBMET03736 0.492 0.009 DBMET03737 | ||
| 0.452 | 0.004 | 0.452 | MAP kinase kinase inhibitor | 0.428 0.004 DBMET03736 0.449 0.004 DBMET03737 | ||
| 0.418 | 0.019 | 0.502 | Calcium channel activator | 0.502 0.005 DBMET03736 0.33 0.065 DBMET03737 | DBMET03736 | |
| 0.398 | 0.018 | 0.398 | Growth factor antagonist | 0.36 0.021 DBMET03736 0.297 0.028 DBMET03737 | ||
| 0.375 | 0.015 | 0.375 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.372 0.016 DBMET03736 0.355 0.019 DBMET03737 | ||
| 0.36 | 0.005 | 0.36 | Granulocyte macrophage colony stimulating factor antagonist | 0.316 0.007 DBMET03736 0.239 0.014 DBMET03737 | ||
| 0.342 | 0.003 | 0.342 | Fibroblast growth factor 2 antagonist | 0.29 0.004 DBMET03736 0.31 0.003 DBMET03737 | ||
| 0.345 | 0.015 | 0.423 | DNA methyltransferase I inhibitor | 0.3 0.026 DBMET03736 0.423 0.007 DBMET03737 | DBMET03737 | |
| 0.379 | 0.06 | 0.379 | Angiogenesis inhibitor | 0.352 0.07 DBMET03736 0.353 0.07 DBMET03737 | ||
| 0.321 | 0.01 | 0.337 | Toll-Like receptor 9 antagonist | 0.269 0.017 DBMET03736 0.337 0.008 DBMET03737 | DBMET03737 | |
| 0.307 | 0.002 | 0.307 | MAP kinase kinase 1 inhibitor | 0.278 0.003 DBMET03736 0.291 0.003 DBMET03737 | ||
| 0.303 | 0.009 | 0.303 | Epidermal growth factor receptor kinase inhibitor | 0.289 0.01 DBMET03736 0.257 0.014 DBMET03737 | ||
| 0.296 | 0.007 | 0.296 | Alpha 2c adrenoreceptor antagonist | 0.295 0.007 DBMET03736 0.26 0.009 DBMET03737 | ||
| 0.306 | 0.026 | 0.374 | DNA methylase inhibitor | 0.258 0.044 DBMET03736 0.374 0.013 DBMET03737 | DBMET03737 | |
| 0.309 | 0.035 | 0.309 | Ca(v)3.3 blocker | 0.297 0.045 DBMET03736 0.271 0.072 DBMET03737 | ||
| 0.286 | 0.04 | 0.286 | EphB2 antagonist | 0.266 0.049 DBMET03736 0.262 0.05 DBMET03737 | ||
| 0.25 | 0.006 | 0.25 | EphA2 antagonist | 0.243 0.007 DBMET03736 0.236 0.008 DBMET03737 | ||
| 0.238 | 0.011 | 0.238 | Epidermal growth factor antagonist | 0.215 0.013 DBMET03736 0.18 0.017 DBMET03737 | ||
| 0.221 | 0.004 | 0.237 | Protein kinase C theta inhibitor | 0.237 0.004 DBMET03736 0.194 0.004 DBMET03737 | DBMET03736 | |
| 0.356 | 0.14 | 0.438 | Caspase 9 stimulant | 0.438 0.09 DBMET03736 0.399 0.112 DBMET03737 | DBMET03736 | |
| 0.234 | 0.02 | 0.288 | Toll-Like receptor antagonist | 0.214 0.026 DBMET03736 0.288 0.008 DBMET03737 | DBMET03737 | |
| 0.228 | 0.018 | 0.228 | Ephrin antagonist | 0.216 0.02 DBMET03736 0.191 0.027 DBMET03737 | ||
| 0.211 | 0.009 | 0.211 | ErbB-2 antagonist | 0.207 0.009 DBMET03736 0.152 0.018 DBMET03737 | ||
| 0.209 | 0.016 | 0.209 | MAP kinase kinase kinase inhibitor | 0.192 0.02 DBMET03736 0.205 0.017 DBMET03737 | ||
| 0.212 | 0.023 | 0.212 | Platelet activating factor antagonist | 0.19 0.029 DBMET03736 0.185 0.031 DBMET03737 | ||
| 0.191 | 0.013 | 0.203 | Insulin growth factor antagonist | 0.172 0.016 DBMET03736 0.203 0.01 DBMET03737 | DBMET03737 | |
| 0.212 | 0.042 | 0.212 | Protein-tyrosine kinase Lyn inhibitor | 0.201 0.046 DBMET03736 0.188 0.05 DBMET03737 | ||
| 0.183 | 0.013 | 0.184 | Insulin like growth factor 1 antagonist | 0.164 0.016 DBMET03736 0.184 0.012 DBMET03737 | DBMET03737 | |
| 0.175 | 0.01 | 0.175 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.161 0.012 DBMET03736 0.142 0.016 DBMET03737 | ||
| 0.204 | 0.04 | 0.211 | Vascular endothelial growth factor 3 antagonist | 0.211 0.038 DBMET03736 0.187 0.047 DBMET03737 | DBMET03736 | |
| 0.172 | 0.014 | 0.189 | Protein kinase C delta inhibitor | 0.189 0.01 DBMET03736 0.174 0.013 DBMET03737 | DBMET03736 | |
| 0.23 | 0.076 | 0.23 | Potassium channel blocker | 0.217 0.082 DBMET03736 0.161 0.124 DBMET03737 | ||
| 0.173 | 0.023 | 0.173 | Platelet activating factor alpha antagonist | 0.161 0.027 DBMET03736 0.159 0.027 DBMET03737 | ||
| 0.174 | 0.032 | 0.204 | Alpha adrenoreceptor antagonist | 0.204 0.027 DBMET03736 0.189 0.029 DBMET03737 | DBMET03736 | |
| 0.213 | 0.072 | 0.219 | Platelet aggregation inhibitor | 0.218 0.069 DBMET03736 0.219 0.069 DBMET03737 | DBMET03737 | |
| 0.186 | 0.046 | 0.204 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.183 0.047 DBMET03736 0.204 0.04 DBMET03737 | DBMET03737 | |
| 0.155 | 0.018 | 0.155 | Platelet growth factor antagonist | 0.136 0.024 DBMET03736 0.149 0.02 DBMET03737 | ||
| 0.169 | 0.032 | 0.169 | Platelet activating factor beta antagonist | 0.143 0.04 DBMET03736 0.148 0.039 DBMET03737 | ||
| 0.182 | 0.049 | 0.182 | Lck kinase inhibitor | 0.176 0.052 DBMET03736 0.175 0.052 DBMET03737 | ||
| 0.153 | 0.037 | 0.162 | Alpha 2b adrenoreceptor antagonist | 0.162 0.034 DBMET03736 0.132 0.049 DBMET03737 | DBMET03736 | |
| 0.133 | 0.024 | 0.133 | ErbB-3 antagonist | 0.109 0.035 DBMET03736 0.105 0.037 DBMET03737 | ||
| 0.139 | 0.031 | 0.158 | Alpha 2 adrenoreceptor antagonist | 0.158 0.025 DBMET03736 0.157 0.025 DBMET03737 | DBMET03736 | |
| 0.124 | 0.028 | 0.145 | Alpha 2a adrenoreceptor antagonist | 0.145 0.023 DBMET03736 0.144 0.024 DBMET03737 | DBMET03736 | |
| 0.133 | 0.039 | 0.133 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.121 0.045 DBMET03736 0.106 0.052 DBMET03737 | ||
| 0.193 | 0.1 | 0.193 | Potassium channel (Voltage-sensitive) blocker | 0.192 0.101 DBMET03736 | ||
| 0.148 | 0.055 | 0.148 | Vascular endothelial growth factor antagonist | 0.126 0.065 DBMET03736 0.137 0.06 DBMET03737 | ||
| 0.224 | 0.132 | 0.25 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.221 0.135 DBMET03736 0.25 0.106 DBMET03737 | DBMET03737 | |
| 0.188 | 0.098 | 0.188 | HERG channel blocker | 0.188 0.098 DBMET03736 0.143 0.137 DBMET03737 | ||
| 0.119 | 0.031 | 0.119 | ErbB-4 antagonist | 0.087 0.048 DBMET03736 0.074 0.057 DBMET03737 | ||
| 0.152 | 0.065 | 0.165 | Activin receptor-like kinase 2 inhibitor | 0.165 0.056 DBMET03736 0.148 0.068 DBMET03737 | DBMET03736 | |
| 0.103 | 0.017 | 0.103 | EphB4 antagonist | 0.071 0.029 DBMET03736 0.065 0.033 DBMET03737 | ||
| 0.133 | 0.055 | 0.133 | Vascular endothelial growth factor 2 antagonist | 0.11 0.066 DBMET03736 0.12 0.06 DBMET03737 | ||
| 0.183 | 0.108 | 0.293 | Cyclic AMP phosphodiesterase inhibitor | 0.174 0.117 DBMET03736 0.293 0.045 DBMET03737 | DBMET03737 | |
| 0.088 | 0.013 | 0.088 | Fibroblast growth factor 4 antagonist | 0.082 0.017 DBMET03736 0.069 0.027 DBMET03737 | ||
| 0.17 | 0.1 | 0.176 | Focal adhesion kinase 2 inhibitor | 0.176 0.092 DBMET03736 | DBMET03736 | |
| 0.137 | 0.068 | 0.149 | RET inhibitor | 0.12 0.079 DBMET03736 0.149 0.062 DBMET03737 | DBMET03737 | |
| 0.171 | 0.103 | 0.214 | MAP kinase kinase 2 inhibitor | 0.155 0.117 DBMET03736 0.214 0.073 DBMET03737 | DBMET03737 | |
| 0.107 | 0.04 | 0.136 | Phosphodiesterase IV inhibitor | 0.136 0.027 DBMET03736 0.077 0.065 DBMET03737 | DBMET03736 | |
| 0.107 | 0.045 | 0.107 | Hepatocyte growth factor antagonist | 0.099 0.052 DBMET03736 0.103 0.049 DBMET03737 | ||
| 0.1 | 0.039 | 0.1 | AXL receptor tyrosine kinase inhibitor | 0.091 0.048 DBMET03736 0.087 0.051 DBMET03737 | ||
| 0.164 | 0.104 | 0.167 | MAP kinase kinase 5 inhibitor | 0.167 0.093 DBMET03736 0.151 0.147 DBMET03737 | DBMET03736 | |
| 0.083 | 0.025 | 0.11 | Potassium channel (ATP-sensitive) blocker | 0.107 0.013 DBMET03736 0.11 0.012 DBMET03737 | DBMET03737 | |
| 0.136 | 0.083 | 0.145 | MAP3K9 inhibitor | 0.141 0.074 DBMET03736 0.145 0.067 DBMET03737 | DBMET03737 | |
| 0.082 | 0.029 | 0.096 | Alpha 1d adrenoreceptor antagonist | 0.096 0.024 DBMET03736 0.06 0.041 DBMET03737 | DBMET03736 | |
| 0.084 | 0.034 | 0.084 | Phosphodiesterase 4B inhibitor | 0.084 0.034 DBMET03736 0.064 0.051 DBMET03737 | ||
| 0.111 | 0.061 | 0.121 | Multidrug resistance-associated protein 1 inhibitor | 0.102 0.075 DBMET03736 0.121 0.047 DBMET03737 | DBMET03737 | |
| 0.097 | 0.049 | 0.097 | Polo-like kinase-1 inhibitor | |||
| 0.141 | 0.095 | 0.141 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.119 0.118 DBMET03736 0.135 0.1 DBMET03737 | ||
| 0.114 | 0.07 | 0.138 | Interleukin 8 antagonist | 0.112 0.073 DBMET03736 0.138 0.043 DBMET03737 | DBMET03737 | |
| 0.078 | 0.04 | 0.087 | Toll-Like receptor 7 antagonist | 0.087 0.031 DBMET03736 0.058 0.057 DBMET03737 | DBMET03736 | |
| 0.116 | 0.082 | 0.12 | Acetylcholinesterase inhibitor | 0.103 0.101 DBMET03736 0.12 0.078 DBMET03737 | DBMET03737 | |
| 0.04 | 0.007 | 0.041 | MAP3K8 inhibitor | 0.041 0.006 DBMET03736 0.033 0.012 DBMET03737 | DBMET03736 | |
| 0.134 | 0.104 | 0.134 | Polo-like kinase-3 inhibitor | |||
| 0.075 | 0.045 | 0.075 | Phosphodiesterase 5A inhibitor | 0.066 0.054 DBMET03736 | ||
| 0.082 | 0.052 | 0.103 | Alpha 1 adrenoreceptor antagonist | 0.103 0.042 DBMET03736 0.084 0.051 DBMET03737 | DBMET03736 | |
| 0.06 | 0.03 | 0.06 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.091 | 0.062 | 0.119 | Antiadrenergic | 0.119 0.046 DBMET03736 0.099 0.057 DBMET03737 | DBMET03736 | |
| 0.092 | 0.064 | 0.092 | Fibroblast growth factor 1 antagonist | |||
| 0.056 | 0.029 | 0.056 | H+/K+-transporting ATPase inhibitor | 0.056 0.029 DBMET03736 0.056 0.029 DBMET03737 | ||
| 0.131 | 0.104 | 0.131 | MAP kinase 3 inhibitor | 0.13 0.108 DBMET03736 | ||
| 0.088 | 0.062 | 0.116 | Adrenaline antagonist | 0.116 0.045 DBMET03736 0.095 0.056 DBMET03737 | DBMET03736 | |
| 0.062 | 0.036 | 0.078 | Heat shock protein 90 beta antagonist | 0.056 0.046 DBMET03736 0.078 0.022 DBMET03737 | DBMET03737 | |
| 0.074 | 0.048 | 0.074 | Phosphodiesterase V inhibitor | 0.066 0.057 DBMET03736 | ||
| 0.095 | 0.069 | 0.095 | Insulin receptor antagonist | |||
| 0.081 | 0.058 | 0.083 | ALK inhibitor | 0.083 0.055 DBMET03736 0.076 0.065 DBMET03737 | DBMET03736 | |
| 0.09 | 0.07 | 0.093 | Butyrylcholinesterase inhibitor | 0.093 0.068 DBMET03737 | DBMET03737 | |
| 0.157 | 0.138 | 0.248 | Antiamyloidogenic | 0.248 0.072 DBMET03737 | DBMET03737 | |
| 0.078 | 0.06 | 0.078 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.068 | 0.051 | 0.069 | ZAP-70 protein tyrosine kinase inhibitor | 0.063 0.057 DBMET03736 0.069 0.049 DBMET03737 | DBMET03737 | |
| 0.05 | 0.034 | 0.051 | Potassium channel (Inward rectifier) blocker | 0.046 0.039 DBMET03736 0.051 0.032 DBMET03737 | DBMET03737 | |
| 0.052 | 0.036 | 0.055 | Alpha 1L adrenoreceptor antagonist | 0.055 0.03 DBMET03736 0.051 0.039 DBMET03737 | DBMET03736 | |
| 0.122 | 0.107 | 0.127 | CC chemokine 6 receptor antagonist | 0.127 0.082 DBMET03737 | DBMET03737 | |
| 0.056 | 0.043 | 0.058 | 5 Hydroxytryptamine 5 antagonist | 0.054 0.046 DBMET03736 0.058 0.039 DBMET03737 | DBMET03737 | |
| 0.05 | 0.038 | 0.061 | CXC chemokine 1 receptor antagonist | 0.061 0.021 DBMET03737 | DBMET03737 | |
| 0.075 | 0.064 | 0.075 | MAP kinase 7 inhibitor | |||
| 0.071 | 0.06 | 0.071 | Focal adhesion kinase 1 inhibitor | 0.069 0.064 DBMET03737 | ||
| 0.107 | 0.097 | 0.107 | Phosphodiesterase inhibitor | 0.104 0.101 DBMET03736 | ||
| 0.064 | 0.06 | 0.066 | Raf kinase inhibitor | 0.066 0.058 DBMET03736 | DBMET03736 | |
| 0.057 | 0.053 | 0.078 | Dopamine D1 antagonist | 0.078 0.034 DBMET03737 | DBMET03737 | |
| 0.097 | 0.095 | 0.097 | Acetylcholine release stimulant | |||
| 0.162 | 0.163 | 0.183 | MAP-kinase-activated kinase 5 inhibitor | 0.168 0.152 DBMET03736 0.183 0.127 DBMET03737 | DBMET03737 | |
| 0.054 | 0.058 | 0.057 | 5 Hydroxytryptamine 5A antagonist | 0.057 0.051 DBMET03737 | DBMET03737 | |
| 0.145 | 0.153 | 0.156 | Growth factor agonist | 0.156 0.129 DBMET03737 | DBMET03737 | |
| 0.053 | 0.064 | 0.07 | Alpha 1a adrenoreceptor antagonist | 0.07 0.051 DBMET03736 | DBMET03736 | |
| 0.133 | 0.156 | 0.145 | Dyrk kinase inhibitor | 0.145 0.141 DBMET03737 | DBMET03737 | |
| 0.04 | 0.064 | 0.052 | Protein kinase C eta inhibitor | 0.052 0.041 DBMET03737 | DBMET03737 | |
| 0.129 | 0.152 | 0.146 | P-glycoprotein inhibitor | 0.146 0.123 DBMET03737 | DBMET03737 | |
| 0.112 | 0.143 | 0.21 | Amyloid beta aggregation inhibitor | 0.21 0.072 DBMET03737 | DBMET03737 | |
| 0.046 | 0.085 | 0.069 | Alpha adrenoreceptor agonist | 0.06 0.055 DBMET03736 0.069 0.047 DBMET03737 | DBMET03737 | |
| 0.072 | 0.113 | 0.095 | Protein kinase C zeta inhibitor | 0.095 0.057 DBMET03737 | DBMET03737 | |
| 0.125 | 0.167 | 0.344 | Aldehyde oxidase inhibitor | 0.344 0.056 DBMET03737 | DBMET03737 | |
| 0.11 | 0.163 | 0.141 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.141 0.129 DBMET03736 | DBMET03736 | |
| 0.047 | 0.111 | 0.071 | MAP-kinase-activated kinase 2 inhibitor | 0.071 0.057 DBMET03736 | DBMET03736 | |
| 0.053 | 0.124 | 0.079 | MAP-kinase-activated kinase inhibitor | 0.079 0.064 DBMET03736 | DBMET03736 | |
| 0.164 | 0.239 | 0.211 | Caspase 3 stimulant | 0.211 0.154 DBMET03737 | DBMET03737 | |
| 0.059 | 0.254 | 0.11 | Interleukin 4 antagonist | 0.11 0.101 DBMET03737 | DBMET03737 | |
| 0.084 | 0.371 | 0.18 | Hypoxia-inducible factor 1 alpha inhibitor | 0.18 0.179 DBMET03737 | DBMET03737 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |